EU says J&J to miss vaccine supply target in second quarter
The European drugs regulator last week said J&J doses sent to Europe from a factory in the United States would not be used as a precaution after a case of contamination
Johnson & Johnson is expected to miss its Covid-19 vaccine supply target to the European Union for the second quarter after about 20 million doses were banned for use out of precaution over safety concerns, a EU Commission spokesman said.
The European drugs regulator last week said J&J doses sent to Europe from a factory in the United States would not be used as a precaution after a case of contamination.
EMA said in a statement to Reuters that 17 million doses had been forbidden from being used in the EU.
Keep updated, follow The Business Standard's Google news channel
"Following the non-release of these batches, the company is not expected to be in a position to deliver 55 million doses by the end of this quarter," which it had committed to shipping under its contract, the EU commission spokesman told Reuters on Wednesday.
